Journey Medical Corporation DERM
6.14
(0.18)
(2.85%)
as of 25 Sep
- Market cap
- $178.4M
- P/E
- 0.0×
Follow DERM
| Dec '17 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
— | 1.65 | 1.65 | 0.87 | 0.44 | 1.25 | 1.42 | 3.05 |
P/FCF ratio |
— | 14.92 | 14.92 | 0.00 | 0.00 | 412.50 | 0.00 | 0.00 |
P/Operating CF |
— | 12.77 | 12.77 | (17.10) | (8.41) | (5.99) | 35.90 | (30.06) |
P/B ratio |
— | 0.00 | 0.00 | 1.30 | 1.90 | 4.86 | 3.98 | 5.93 |
Price to Tangible BV |
— | 0.00 | 0.00 | 1.86 | 0.00 | 1,571.42 | 0.00 | 44.47 |
EV/Sales |
— | 1.61 | 1.61 | 0.16 | 0.31 | 1.13 | 1.56 | 3.16 |
EV/EBITDA |
— | 0.00 | 0.00 | 0.00 | 0.00 | 17.19 | 0.00 | 0.00 |
EV/Operating CF |
— | 14.56 | 14.56 | (4.67) | (1.70) | 17.04 | (9.59) | (15.73) |
EV/FCF |
— | 14.56 | 14.56 | (0.77) | (0.69) | 372.00 | (3.63) | (7.13) |
Quick Ratio |
— | 1.14 | 1.15 | 1.40 | 0.90 | 1.02 | 0.87 | 1.44 |
Current Ratio |
— | 1.21 | 1.26 | 1.64 | 1.16 | 1.35 | 1.37 | 1.79 |
Net Debt/EBITDA |
— | 0.08 | 0.17 | 1.50 | 0.40 | (2.47) | (0.46) | (0.35) |
Debt/Assets |
0.00% | 15.66% | 18.93% | 4.56% | 21.66% | 19.03% | 31.01% | 26.72% |
Debt/Equity |
— | 1.93 | 0.95 | 0.11 | 1.34 | 0.72 | 1.24 | 0.79 |
Asset Turnover |
— | 2.06 | 1.04 | 0.85 | 0.73 | 0.87 | 0.71 | 0.71 |
Operating CF/Net income |
— | 2.49 | 0.97 | 0.05 | 0.46 | (1.36) | 0.62 | 1.09 |
Capex/Depreciation |
— | (1.90) | (0.79) | (1.95) | (4.52) | (0.69) | (3.92) | 0.00 |
Interest Coverage |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| — | 55.58% | 81.00% | (168.12%) | (100.39%) | (20.64%) | (72.60%) | (44.03%) | |
| — | 21.41% | 12.32% | (58.98%) | (29.27%) | (4.23%) | (18.68%) | (13.08%) | |
ROIC |
— | 101.01% | 41.33% | 0.00% | (221.83%) | (17.20%) | (34.69%) | (15.46%) |
Return on Tangible Assets |
— | 82.84% | 71.82% | (133.44%) | (268.47%) | (26.41%) | (112.83%) | (38.84%) |
Average Days of Receivables |
— | 198.12 | 196.13 | 133.62 | 139.76 | 70.17 | 66.53 | 175.74 |
Research and Development Expense of Revenue |
— | 0.00% | 0.00% | 26.23% | 14.85% | 9.52% | 17.56% | 0.78% |
Selling, General and Administrative Expense of Revenue |
— | 54.78% | 49.60% | 63.09% | 80.72% | 55.46% | 71.62% | 71.73% |
Intangible Assets out of Total Assets |
0.00 | 0.22 | 0.29 | 0.13 | 0.26 | 0.26 | 0.40 | 0.29 |
Share Based Compensation of Revenue |
— | 0.69% | 0.34% | 3.91% | 6.01% | 3.29% | 10.86% | 10.17% |
Graham Net Nets |
— | (0.37) | (0.37) | 0.53 | (0.33) | 0.00 | (0.15) | 0.02 |
Graham Number |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
— | (24.52%) | (24.52%) | (75.66%) | (91.30%) | (4.42%) | (18.93%) | (6.10%) |
Free Cash Flow Yield |
— | 6.70% | 6.70% | (24.04%) | (103.96%) | 0.24% | (30.20%) | (14.53%) |
Revenue per Share |
— | 3.82 | 4.87 | 6.20 | 4.20 | 4.34 | 2.75 | 2.53 |
Operating CF per Share |
— | 0.99 | 0.56 | (0.21) | (0.77) | 0.29 | (0.45) | (0.51) |
Capex per Share |
— | (0.26) | (0.13) | (0.98) | (1.14) | (0.27) | (0.73) | 0.00 |
Free Cash Flow per Share |
— | 0.72 | 0.43 | (1.20) | (1.91) | 0.01 | (1.18) | (0.51) |
Cash per Share |
— | 0.53 | 0.90 | 4.82 | 1.83 | 1.51 | 0.99 | 0.98 |
Shareholders Equity per Share |
— | 0.30 | 1.13 | 4.13 | 0.97 | 1.12 | 0.98 | 1.30 |
Interest Debt per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | 0.30 | 1.13 | 4.13 | 0.97 | 1.12 | 0.98 | 1.30 |
Free Cash Flow |
— | 6.62 | 3.93 | (12.18) | (33.53) | 0.24 | (24.13) | (12.44) |
Working Capital |
— | 4.37 | 7.18 | 32.88 | 10.85 | 14.59 | 13.00 | 29.43 |
Capital Expenditures |
— | (2.40) | (1.20) | (10.00) | (20.00) | (5.00) | (15.00) | 0.00 |
Net Current Asset Value |
— | (5.84) | (6.37) | 29.25 | (10.50) | (0.04) | (11.99) | 4.14 |
EV/EBIT |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
— | 0.07 | 0.03 | 0.16 | 0.27 | 0.06 | 0.27 | 0.00 |
Net Profit Margin |
— | 10.38% | 11.86% | (69.68%) | (40.22%) | (4.87%) | (26.14%) | (18.48%) |
Price to Operating Income |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||
Depreciation/Fixed assets |
— | 252.80 | 8.66 | 57.66 | 23.43 | 0.00 | 0.00 | 0.00 |
Cash ROIC |
— | 70.11% | 17.48% | (2.38%) | (19.12%) | 8.40% | (13.99%) | (15.32%) |
Accounts Receivable Turnover |
— | 1.63 | 2.08 | 2.68 | 2.87 | 3.65 | 4.41 | 3.09 |
Accounts Payable Turnover |
— | 5.18 | 7.18 | 2.53 | 1.02 | 0.83 | 1.21 | 1.68 |
Inventory Turnover |
— | 9.32 | 12.91 | 5.70 | 2.56 | 1.88 | 1.69 | 1.74 |
Average Days of Payables |
— | 73.06 | 48.92 | 266.81 | 438.63 | 292.47 | 280.58 | 154.40 |
Days of Inventory on Hand |
— | 29.70 | 35.11 | 112.19 | 167.93 | 162.72 | 252.28 | 167.88 |
Average Receivables |
— | 21.44 | 21.44 | 23.52 | 25.66 | 21.72 | 12.73 | 20.01 |
Average Payables |
— | 2.03 | 2.03 | 12.70 | 30.22 | 27.66 | 17.20 | 12.45 |
Average Inventory |
— | 1.13 | 1.13 | 5.63 | 12.01 | 12.18 | 12.32 | 12.03 |
Average Assets |
— | 16.93 | 42.88 | 74.60 | 101.22 | 91.00 | 78.55 | 87.42 |
Average Common Equity |
— | 6.52 | 6.52 | 26.17 | 29.51 | 18.67 | 20.21 | 25.96 |
Columns are period end dates